Sara Gandolfi

University of Helsinki — Finland

Medicine · Health Sciences

15h-index1.2kcitations84works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(28), Protein Degradation and Inhibitors(22), Immune Cell Function and Interaction(18), CRISPR and Genetic Engineering(11), T-cell and B-cell Immunology(9)

Publications84 total

Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response
Nature Communications·2026Open Access
Negative regulators of survival and proliferation (NRSPs) identified by CRISPR activation studies in multiple myeloma (MM) vs. other neoplasias: Therapeutic implications
Blood·2025Open Access
From the discovery of novel enzymes to their synthetic application: investigating and harnessing natural biodiversity toward efficient and selective bioprocesses
New Biotechnology·2025Open Access
Bone Marrow Stromal Cells Hamper Leukemia Cell Induced NK Cell Activation and Cytotoxicity
Blood·2024· 3 cited
Comprehensive Drug Profiling and CRISPR Screening Reveal Essential Pathways for NK Cell Cytotoxicity
Blood·2024Open Access
Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers
Immunity·2023· 56 citedOpen Access
Natural Killer Cells Are Active Against Myeloma, Leukemia or Lymphoma Cells with Loss of Tumor Suppressor Genes
Blood·2023Open Access
P-182 Natural killer cells are active against myeloma cells with loss of tumor suppressor genes
Clinical Lymphoma Myeloma & Leukemia·2023
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias
Nature Cancer·2023· 34 citedOpen Access
Abstract 667: Single-cell functional genomics of natural killer cell evasion by tumor cells
Cancer Research·2023
Single-Cell Functional Genomics of Natural Killer Cell Interaction with Blood Cancers
Blood·2022· 2 cited
1006 Single-cell functional genomics of natural killer cell evasion in blood cancers
Regular and Young Investigator Award Abstracts·2022· 2 citedOpen Access
Single-cell functional genomics of natural killer cell evasion in blood cancers
2022· 3 citedOpen Access
Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review
British Journal of Haematology·2022· 19 citedOpen Access
Functional Oncogenomic and Immune Response Landscape for Genes Recurrently Mutated in Myeloma
Blood·2021
Functional Genomic and Immune Response Characterization of PTEN Loss: Therapeutic Implications for Myeloma
Blood·2021· 1 cited
Functional Genomic Landscape of Natural Killer Cell Evasion in Multiple Myeloma
Blood·2021· 2 cited
OAB-019: CRISPR screens with single-cell transcriptome readout reveal potential mechanisms of response to natural killer cell treatment in multiple myeloma
Clinical Lymphoma Myeloma & Leukemia·2021· 1 cited
Genome-scale screens identify factors regulating tumor cell responses to natural killer cells
Nature Genetics·2021· 93 citedOpen Access
Abstract PO041: Landscape of molecular events regulating tumor cell responses to natural killer cells
Cancer Immunology Research·2021
page 1 of 5Next →

Frequent Co-authors

Constantine S. Mitsiades(29), Ricardo De Matos Simoes(27), Michal Sheffer(27), Olga Dashevsky(25), Ryosuke Shirasaki(21), Huihui Tang(14), Eugen Dhimolea(14), Megan Bariteau(13), Brian Glassner(13), Aedín C. Culhane(13), Paul G. Richardson(12), Geoffrey M. Matthews(12), Sondra L. Downey-Kopyscinski(12), Francisca Vázquez(12), Aviad Tsherniak(12), Jonathan D. Licht(12), Armando Santoro(10), Satu Mustjoki(10), Jacob P. Laubach(9), Richard W.J. Groen(9)